Exact Mass: 258.0641

Exact Mass Matches: 258.0641

Found 25 metabolites which its exact mass value is equals to given mass value 258.0641, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Thalidomide

2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione

C13H10N2O4 (258.0641)


A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppresive and anti-angiogenic activity. It inhibits release of tumor necrosis factor-alpha from monocytes, and modulates other cytokine action. [PubChem] CONFIDENCE standard compound; INTERNAL_ID 427; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4434; ORIGINAL_PRECURSOR_SCAN_NO 4432 CONFIDENCE standard compound; INTERNAL_ID 427; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4447; ORIGINAL_PRECURSOR_SCAN_NO 4445 CONFIDENCE standard compound; INTERNAL_ID 427; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4440; ORIGINAL_PRECURSOR_SCAN_NO 4437 CONFIDENCE standard compound; INTERNAL_ID 427; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4431; ORIGINAL_PRECURSOR_SCAN_NO 4428 CONFIDENCE standard compound; INTERNAL_ID 427; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4457; ORIGINAL_PRECURSOR_SCAN_NO 4455 DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; CONFIDENCE standard compound; INTERNAL_ID 427; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; ORIGINAL_ACQUISITION_NO 4447; ORIGINAL_PRECURSOR_SCAN_NO 4445 CONFIDENCE standard compound; INTERNAL_ID 427; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4523; ORIGINAL_PRECURSOR_SCAN_NO 4521 C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent > C157388 - Immunomodulatory Imide Drug COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007917 - Leprostatic Agents D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D006133 - Growth Substances > D006131 - Growth Inhibitors D009676 - Noxae > D013723 - Teratogens Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Myxin

1-hydroxy-6-methoxyphenazine-5,10-diium-5,10-bis(olate)

C13H10N2O4 (258.0641)


   
   

2,3-Dihydro-2,3-dioxoaaptamine

2,3-Dihydro-2,3-dioxoaaptamine

C13H10N2O4 (258.0641)


   

thalidomide

thalidomide

C13H10N2O4 (258.0641)


C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent > C157388 - Immunomodulatory Imide Drug COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007917 - Leprostatic Agents D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D006133 - Growth Substances > D006131 - Growth Inhibitors D009676 - Noxae > D013723 - Teratogens Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-Amino-3-hydroxy-5-nitrobenzophenone

2-Amino-3-hydroxy-5-nitrobenzophenone

C13H10N2O4 (258.0641)


   

3-[(4-Carboxyphenyl)carbamoyl]pyridine 1-oxide

3-[(4-Carboxyphenyl)carbamoyl]pyridine 1-oxide

C13H10N2O4 (258.0641)


   

N-(2-hydroxyphenyl)-2-nitrobenzamide

N-(2-hydroxyphenyl)-2-nitrobenzamide

C13H10N2O4 (258.0641)


   

3-[(3-Carboxyphenyl)carbamoyl]pyridine 1-oxide

3-[(3-Carboxyphenyl)carbamoyl]pyridine 1-oxide

C13H10N2O4 (258.0641)


   

4-Anilino-3-nitrobenzoic acid

4-Anilino-3-nitrobenzoic acid

C13H10N2O4 (258.0641)


   

BIS(P-NITROPHENYL)METHANE

BIS(P-NITROPHENYL)METHANE

C13H10N2O4 (258.0641)


   

2-PHENYLAMINO-3-NITROBENZOIC ACID

2-PHENYLAMINO-3-NITROBENZOIC ACID

C13H10N2O4 (258.0641)


   

4-[4-(1H-IMIDAZOL-1-YL)PHENYL]-2,4-DIOXO-BUTANOIC ACID

4-[4-(1H-IMIDAZOL-1-YL)PHENYL]-2,4-DIOXO-BUTANOIC ACID

C13H10N2O4 (258.0641)


   

3-Cyano-4-hydroxy-7-methoxy-6-quinolinyl acetate

3-Cyano-4-hydroxy-7-methoxy-6-quinolinyl acetate

C13H10N2O4 (258.0641)


   

(+)-Thalidomide

(R)-(+)-Thalidomide

C13H10N2O4 (258.0641)


   

(S)-Thalidomide

(S)-Thalidomide

C13H10N2O4 (258.0641)


   

2-(4-NITRO-PHENYLAMINO)-BENZOIC ACID

2-(4-NITRO-PHENYLAMINO)-BENZOIC ACID

C13H10N2O4 (258.0641)


   

4-nitrophenyl anthranilate

4-nitrophenyl anthranilate

C13H10N2O4 (258.0641)


   

2-(3-Nitrophenoxy)Benzamide

2-(3-Nitrophenoxy)Benzamide

C13H10N2O4 (258.0641)


   

2,4-Dinitrdiphenylmethane

2,4-Dinitrdiphenylmethane

C13H10N2O4 (258.0641)


   

4,6,8-Trihydroxydibenzodiazepinone

4,6,8-Trihydroxydibenzodiazepinone

C13H10N2O4 (258.0641)


   

4-Oxo-3-pyrimido[2,1-b][1,3]benzoxazolecarboxylic acid ethyl ester

4-Oxo-3-pyrimido[2,1-b][1,3]benzoxazolecarboxylic acid ethyl ester

C13H10N2O4 (258.0641)


   

5-acetyl-3-amino-1,4-dioxonaphthalene-2-carboximidic acid

5-acetyl-3-amino-1,4-dioxonaphthalene-2-carboximidic acid

C13H10N2O4 (258.0641)


   

5-acetyl-1-hydroxy-3-imino-4-oxonaphthalene-2-carboximidic acid

5-acetyl-1-hydroxy-3-imino-4-oxonaphthalene-2-carboximidic acid

C13H10N2O4 (258.0641)


   

phenyl 3-amino-5-nitrobenzoate

phenyl 3-amino-5-nitrobenzoate

C13H10N2O4 (258.0641)